2930 Stock Overview
Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Kitanotatsujin Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥203.00 |
52 Week High | JP¥363.00 |
52 Week Low | JP¥178.00 |
Beta | 0.40 |
1 Month Change | -8.56% |
3 Month Change | -4.25% |
1 Year Change | -39.40% |
3 Year Change | -68.13% |
5 Year Change | -57.97% |
Change since IPO | 493.42% |
Recent News & Updates
Shareholder Returns
2930 | JP Personal Products | JP Market | |
---|---|---|---|
7D | -1.0% | -2.1% | 1.7% |
1Y | -39.4% | -15.3% | 37.6% |
Return vs Industry: 2930 underperformed the JP Personal Products industry which returned -15.1% over the past year.
Return vs Market: 2930 underperformed the JP Market which returned 38.6% over the past year.
Price Volatility
2930 volatility | |
---|---|
2930 Average Weekly Movement | 5.1% |
Personal Products Industry Average Movement | 3.7% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2930 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2930's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 213 | Katsuhisa Kinoshita | https://www.kitanotatsujin.com |
Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company also sell its products through its e-commerce website.
Kitanotatsujin Corporation Fundamentals Summary
2930 fundamental statistics | |
---|---|
Market cap | JP¥28.24b |
Earnings (TTM) | JP¥612.00m |
Revenue (TTM) | JP¥14.22b |
46.2x
P/E Ratio2.0x
P/S RatioIs 2930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2930 income statement (TTM) | |
---|---|
Revenue | JP¥14.22b |
Cost of Revenue | JP¥3.73b |
Gross Profit | JP¥10.49b |
Other Expenses | JP¥9.88b |
Earnings | JP¥612.00m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
Apr 12, 2024
Earnings per share (EPS) | 4.40 |
Gross Margin | 73.78% |
Net Profit Margin | 4.30% |
Debt/Equity Ratio | 0% |
How did 2930 perform over the long term?
See historical performance and comparison